Your browser doesn't support javascript.
loading
Risk Factors for Severe COVID-19 in Children.
Woodruff, Rebecca C; Campbell, Angela P; Taylor, Christopher A; Chai, Shua J; Kawasaki, Breanna; Meek, James; Anderson, Evan J; Weigel, Andy; Monroe, Maya L; Reeg, Libby; Bye, Erica; Sosin, Daniel M; Muse, Alison; Bennett, Nancy M; Billing, Laurie M; Sutton, Melissa; Talbot, H Keipp; McCaffrey, Keegan; Pham, Huong; Patel, Kadam; Whitaker, Michael; L McMorrow, Meredith; P Havers, Fiona.
Afiliação
  • Woodruff RC; CDC COVID-19 Response Team.
  • Campbell AP; US Public Health Service Commissioned Corps, Rockville, Maryland.
  • Taylor CA; CDC COVID-19 Response Team.
  • Chai SJ; CDC COVID-19 Response Team.
  • Kawasaki B; US Public Health Service Commissioned Corps, Rockville, Maryland.
  • Meek J; Division of State and Local Readiness, Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Anderson EJ; California Emerging Infections Program, Oakland, California.
  • Weigel A; Colorado Department of Public Health and Environment, Denver, Colorado.
  • Monroe ML; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut.
  • Reeg L; Departments of Medicine and Pediatrics, Emory School of Medicine, Atlanta, Georgia.
  • Bye E; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, Georgia.
  • Sosin DM; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Muse A; Iowa Department of Public Health, Des Moines, Iowa.
  • Bennett NM; Maryland Department of Health, Baltimore, Maryland.
  • Billing LM; Michigan Department of Health and Human Services, Lansing, Michigan.
  • Sutton M; Minnesota Department of Health, St Paul, Minnesota.
  • Talbot HK; New Mexico Emerging Infections Program, Santa Fe, New Mexico.
  • McCaffrey K; New Mexico Department of Health, Santa Fe, New Mexico.
  • Pham H; New York State Department of Health, Albany, New York.
  • Patel K; University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Whitaker M; Ohio Department of Health, Columbus, Ohio.
  • L McMorrow M; Public Health Division, Oregon Health Authority, Portland, Oregon.
  • P Havers F; Vanderbilt University Medical Center, Nashville, Tennesee.
Pediatrics ; 149(1)2022 01 01.
Article em En | MEDLINE | ID: mdl-34935038
ABSTRACT

OBJECTIVES:

Describe population-based rates and risk factors for severe coronavirus disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death) among hospitalized children.

METHODS:

During March 2020 to May 2021, the COVID-19-Associated Hospitalization Surveillance Network identified 3106 children hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection in 14 states. Among 2293 children primarily admitted for COVID-19, multivariable generalized estimating equations generated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) of the associations between demographic and medical characteristics abstracted from medical records and severe COVID-19. We calculated age-adjusted cumulative population-based rates of severe COVID-19 among all children.

RESULTS:

Approximately 30% of hospitalized children had severe COVID-19; 0.5% died during hospitalization. Among hospitalized children aged <2 years, chronic lung disease (aRR 2.2; 95% CI 1.1-4.3), neurologic disorders (aRR 2.0; 95% CI 1.5‒2.6), cardiovascular disease (aRR 1.7; 95% CI 1.2‒2.3), prematurity (aRR 1.6; 95% CI 1.1‒2.2), and airway abnormality (aRR 1.6; 95% CI 1.1‒2.2) were associated with severe COVID-19. Among hospitalized children aged 2 to 17 years, feeding tube dependence (aRR 2.0; 95% CI 1.5‒2.5), diabetes mellitus (aRR 1.9; 95% CI 1.6‒2.3) and obesity (aRR 1.2; 95% CI 1.0‒1.4) were associated with severe COVID-19. Severe COVID-19 occurred among 12.0 per 100 000 children overall and was highest among infants, Hispanic children, and non-Hispanic Black children.

CONCLUSIONS:

Results identify children at potentially higher risk of severe COVID-19 who may benefit from prevention efforts, including vaccination. Rates establish a baseline for monitoring changes in pediatric illness severity after increased availability of COVID-19 vaccines and the emergence of new variants.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article